This website uses cookies to ensure you get the best experience on our website.

Biocrucible and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking "Manage cookies" at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, which is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor
Biocrucible
Picture of Matthew Forrest

Matthew Forrest

Lead Scientist – Research & Development

 

Matthew Forrest is a Lead Scientist at Biocrucible with >15 years of experience with Recombinase Polymerase Amplification (RPA) isothermal DNA amplification technology and point-of care diagnostics.

At TwistDx he developed several IVD tests, led development of the TwistAmp Liquid kit and made critical contributions to the development of the Alere-i (Abbott ID NOW) platform, the first CLIA-waived molecular testing platform.

Since working as an instructor on workshops for the Wellcome Trust in LMIC, Matthew has been interested in developing affordable, workable molecular diagnostics that are suitable for the needs of such resource limited settings.

Matthew received his Bachelor’s and Master’s degree from University of York and his Molecular Biology PhD from the Imperial Cancer Research Fund and undertook post doctoral studies at UC Berkeley and the Wellcome Trust Sanger Institute. 


 

Some of my colleagues

Picture of Hannah Williams
Hannah Williams
Yasin Kurmoo
Hema Harilal
Research Assistant
Selina Clayton
Senior Scientist - Lateral Flow

About Biocrucible

Biocrucible, a Sapphiros group company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications.

 

    Founded in 2021

    Already working at Biocrucible?

    Let’s recruit together and find your next colleague.

    @biocrucible.co.uk